CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +6,455 | $30.93 | $200K | 76,377 |
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +11,958 | $17.92 | $214K | 88,335 |
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −899 | $92.37 | $83K | 87,436 |
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −16,810 | $93.42 | $1.6M | 70,626 |
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −704 | $94.09 | $66K | 69,922 |
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −6,455 | 0 | ||
| 2026-11-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −11,958 | 0 | ||
| 2026-11-02 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +53,381 | $8.83 | $471K | 959,314 |
| 2026-11-02 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −38,364 | $91.03 | $3.5M | 920,950 |
| 2026-11-02 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −24,188 | $91.83 | $2.2M | 896,762 |
| 2026-11-02 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −26,781 | $93.06 | $2.5M | 869,981 |
| 2026-11-02 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −100 | $93.97 | $9K | 869,881 |
| 2026-11-02 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −53,381 | 89,089 | ||
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +16,111 | $10.76 | $173K | 32,418 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +21,059 | $11.10 | $234K | 53,477 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +3,760 | $11.97 | $45K | 57,237 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +1,658 | $12.97 | $22K | 58,895 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +16,112 | $17.76 | $286K | 75,007 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,895 | $18.06 | $197K | 85,902 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −37,775 | $92.00 | $3.5M | 48,127 |
Page 3 of 74 · 1,467 trades